While numerous studies have already examined the effectiveness of ATM and ATR inhibition alone or in combination with RT for different cancer types, there remains a notable gap in directly comparing their impact on the immunogenicity of HNSCC cells (16–19). The gene discussed is ATM; the disease is head and neck squamous cell carcinoma.